The neuro-ophthalmological manifestations of NMOSD and MOGAD-a comprehensive review.
Publication/Presentation Date
8-1-2023
Abstract
Optic neuritis (ON) is one of the most frequently seen neuro-ophthalmic causes of vision loss worldwide. Typical ON is often idiopathic or seen in patients with multiple sclerosis, which is well described in the landmark clinical trial, the Optic Neuritis Treatment Trial (ONTT). However, since the completion of the ONTT, there has been the discovery of aquaporin-4 (AQP4) and myelin oligodendrocyte glycoprotein (MOG) antibodies, which are biomarkers for neuromyelitis optica spectrum disorder (NMOSD) and MOG antibody-associated disease (MOGAD), respectively. These disorders are associated with atypical ON that was not well characterised in the ONTT. The severity, rate of recurrence and overall outcome differs in these two entities requiring prompt and accurate diagnosis and management. This review will summarise the characteristic neuro-ophthalmological signs in NMOSD and MOGAD, serological markers and radiographic findings, as well as acute and long-term therapies used for these disorders.
Volume
37
Issue
12
First Page
2391
Last Page
2398
ISSN
1476-5454
Published In/Presented At
Moheb, N., & Chen, J. J. (2023). The neuro-ophthalmological manifestations of NMOSD and MOGAD-a comprehensive review. Eye (London, England), 37(12), 2391–2398. https://doi.org/10.1038/s41433-023-02477-0
Disciplines
Medicine and Health Sciences
PubMedID
36928226
Department(s)
Department of Medicine
Document Type
Article